Richmond Pharmacology contributed 98 of the 124 patients enrolled in this study, five times more than the next site in terms of recruitment. We are proud of our extraordinary contribution to this study, all achieved during the confines of a global pandemic. Our dedicated team of physicians and researchers worked tirelessly during this time to bring about a potential breakthrough in the treatment of hypertension.

Zilebesiran data was previously presented at the American Heart Association (AHA)Scientific Sessions in November 2021 : Alnylam Pharmaceuticals Press Release | Nov 13, 2021 | Alnylam Presents New Data for Zilebesiran, an Investigational RNAi Therapeutic for the Treatment of Hypertension.

Hypertension (high blood pressure) affects over 1 billion patients globally, posing serious health risks. Hypertension is a major risk factor for ischemic heart disease, stroke, and chronic kidney disease and is the leading preventable factor in death from cardiovascular causes worldwide.

We are thrilled to share this important research that could potentially revolutionize hypertension management.  The New England Journal of Medicine's recognition is a testament to the importance and impact of this research.

We invite you to read the full article in the New England Journal of Medicine to delve into the details of the trial. Discover how Zilbesiran, this innovative anti-hypertensive injectable, may pave the way for more effective, targeted approaches to blood pressure management.

Latest news

Engaging Hearts and Hands: A Day of Volunteering at Arc Nursery

September 12, 2023
Discover how Richmond's dedicated team of volunteers is making a positive impact on young minds at Arc Nursery
Read more

Exciting Research Update: Enhancing Blinding in Clinical Trials with Auto-Injectors

September 5, 2023
We’re excited to share the findings of our recent study on the use of auto-injector systems (A-INJ) in randomized controlled trials (RCTs) by Dr Jorg Taubel, Dr Ulrike Lorch, Dr Thomas York and Vishal Aggarwal.
Read more


BioJapan 2023

11-13 October 2023
BioJapan is "Asia's largest partnering event consisting of Exhibition, Seminar, and Partnering program".
View event